cGMP signalling in the mammalian brain: role in synaptic plasticity and behaviour

Area of Science:

• Neuroscience
• Molecular Biology
• Biochemistry

Background:

• The role of cyclic guanosine 3',5'-monophosphate (cGMP) in neuronal function is less understood than its cardiovascular and gastrointestinal roles.
• cGMP is a critical second messenger involved in various physiological processes.

Purpose of the Study:

• To review recent biochemical and functional data on the cGMP signaling pathway in the mammalian brain.
• To explore the involvement of cGMP in synaptic plasticity, learning, and complex behaviors.
• To identify potential therapeutic targets for neurological and psychiatric disorders.

Main Methods:

• Expression profiling
• Pharmacological manipulations
• Genetic manipulations
• Behavioral studies

Main Results:

• Nitric oxide-sensitive soluble guanylyl cyclases (sGCs), cGMP-dependent protein kinases (cGKs), and phosphodiesterases (PDEs) are key regulators of cGMP signaling in the brain.
• The canonical NO/sGC/cGMP/cGK pathway influences synaptic plasticity in brain regions like the hippocampus and amygdala.
• cGMP signaling is implicated in learning, memory, anxiety, addiction, depression, and schizophrenia.
• cGKs modulate synaptic transmission and neuronal functions by phosphorylating various substrates, affecting cytoskeletal organization, receptor trafficking, and gene expression.

Conclusions:

• The cGMP signaling pathway is crucial for diverse neuronal functions, including learning and behavior.
• Components of the cGMP cascade represent promising therapeutic targets for cognitive impairments, drug abuse, and psychiatric conditions.